Terms: = Lymphoma AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
898 results:
1. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
Li X; Wu D; Tang J; Wu Y
J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
[TBL] [Abstract] [Full Text] [Related]
2. Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell lymphoma: Insights into treatment Outcomes.
Xie Z; Qin Y; Chen X; Yang S; Yang J; Gui L; Liu P; He X; Zhou S; Zhang C; Tang L; Shi Y
Target Oncol; 2024 May; 19(3):383-400. PubMed ID: 38643457
[TBL] [Abstract] [Full Text] [Related]
3. Aerobic exercise training combined with local strength exercise restores muscle blood flow and maximal aerobic capacity in long-term Hodgkin lymphoma survivors.
Santos LS; Rehder MHHDS; Negrao MV; Goes-Santos BR; Toshi Dias E; Paixão CJ; Urias U; Giannetti NS; Hajjar LA; Filho RK; Negrão CE
Am J Physiol Heart Circ Physiol; 2024 Jun; 326(6):H1462-H1468. PubMed ID: 38639741
[TBL] [Abstract] [Full Text] [Related]
4. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Park SJ; Ju S; Goh SH; Yoon BH; Park JL; Kim JH; Lee S; Lee SJ; Kwon Y; Lee W; Park KC; Lee GK; Park SY; Kim S; Kim SY; Han JY; Lee C
Cancer Res; 2024 May; 84(9):1491-1503. PubMed ID: 38607364
[TBL] [Abstract] [Full Text] [Related]
5. Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin lymphoma: A Systematic Review and Meta-Analysis.
Yamshon S; Gribbin C; Alhomoud M; Chokr N; Chen Z; Demetres M; Pasciolla M; Leonard J; Shore T; Martin P
Clin Lymphoma Myeloma Leuk; 2024 Jun; 24(6):e235-e256.e2. PubMed ID: 38582666
[TBL] [Abstract] [Full Text] [Related]
6. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
[TBL] [Abstract] [Full Text] [Related]
7. Lysine demethylase LSD1 is associated with stemness in EBV-positive B cell lymphoma.
Kim JH; Park C; Kim WS
Sci Rep; 2024 Mar; 14(1):6764. PubMed ID: 38514636
[TBL] [Abstract] [Full Text] [Related]
8. Interesting case of regional left ventricular hypertrophy.
Elsaid A; Egdell R; Singh V; Russell S
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38490700
[TBL] [Abstract] [Full Text] [Related]
9. An ensemble-acute lymphoblastic leukemia model for acute lymphoblastic leukemia image classification.
Huang ML; Huang ZB
Math Biosci Eng; 2024 Jan; 21(2):1959-1978. PubMed ID: 38454670
[TBL] [Abstract] [Full Text] [Related]
10. Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
Liu Y; Ping L; Song Y; Tang Y; Zheng W; Liu W; Ying Z; Zhang C; Wu M; Feng F; Lin N; Tu M; Zhu J; Xie Y
BMC Med; 2024 Mar; 22(1):107. PubMed ID: 38454451
[TBL] [Abstract] [Full Text] [Related]
11. Post Renal Transplant Malignancies; A Basic Concept.
Nabi Z; Zahid T; Nabi R
J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
[TBL] [Abstract] [Full Text] [Related]
12. Socioeconomic status and adiposity in childhood cancer survivors: A cross-sectional retrospective study.
Štrublová L; Kepák T; Kuruczová D; Zlámal F; Holíková M; Kepáková K; Štěrba J; Bienertová-Vašků J
PLoS One; 2024; 19(2):e0298068. PubMed ID: 38363727
[TBL] [Abstract] [Full Text] [Related]
13. Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally.
Ali N; Amare E; Fekadu A; Awol M; Kayode O; Gebresenbet M; Nasir K; Dresser SA; Schriebmann E; Seife E; Esiashvili N
JCO Glob Oncol; 2024 Feb; 10():e2300345. PubMed ID: 38359372
[TBL] [Abstract] [Full Text] [Related]
14. Utility of contrast-enhanced MRI radiomics features combined with clinical indicators for predicting induction chemotherapy response in primary central nervous system lymphoma.
Wang X; Zhao L; Wang S; Zhao X; Chen L; Sun X; Liu Y; Liu J; Sun S
J Neurooncol; 2024 Feb; 166(3):451-460. PubMed ID: 38308802
[TBL] [Abstract] [Full Text] [Related]
15. High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.
Schorb E; Isbell LK; Kerkhoff A; Mathas S; Braulke F; Egerer G; Röth A; Schliffke S; Borchmann P; Brunnberg U; Kroschinsky F; Möhle R; Rank A; Wellnitz D; Kasenda B; Pospiech L; Wendler J; Scherer F; Deckert M; Henkes E; von Gottberg P; Gmehlin D; Backenstraß M; Jensch A; Burger-Martin E; Grishina O; Fricker H; Malenica N; Orbán A; Duyster J; Ihorst G; Finke J; Illerhaus G
Lancet Haematol; 2024 Mar; 11(3):e196-e205. PubMed ID: 38301670
[TBL] [Abstract] [Full Text] [Related]
16. Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.
Dhawale T; Johnson PC; Boateng K; Barata A; Traeger L; Nelson AM; Lavoie MW; Holmbeck K; Choe J; Nabily A; Tripathi A; Amonoo HL; Frigault M; El-Jawahri A
Transplant Cell Ther; 2024 Apr; 30(4):402.e1-402.e12. PubMed ID: 38262530
[TBL] [Abstract] [Full Text] [Related]
17. A comprehensive study for selecting optimal treatment modalities for blood cancer in a Fermatean fuzzy dynamic environment.
Alghazzawi D; Noor A; Alolaiyan H; El-Wahed Khalifa HA; Alburaikan A; Dai S; Razaq A
Sci Rep; 2024 Jan; 14(1):1896. PubMed ID: 38253693
[TBL] [Abstract] [Full Text] [Related]
18. Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance.
Maruyama D; Omi A; Nomura F; Touma T; Noguchi Y; Takebe K; Izutsu K
Int J Hematol; 2024 Feb; 119(2):146-155. PubMed ID: 38195971
[TBL] [Abstract] [Full Text] [Related]
19. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
[TBL] [Abstract] [Full Text] [Related]
20. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Goto H; Ito S; Kizaki M; Yamaguchi M; Fukuhara N; Kato K; Saito T; Terui Y; Okubo S; Soshin T; Zeng J; Honda H; Badawi M; Ross JA; Izutsu K
Int J Clin Oncol; 2024 Feb; 29(2):232-240. PubMed ID: 38157190
[TBL] [Abstract] [Full Text] [Related]
[Next]